Vanguard Fiduciary Trust
LENZ

Vanguard Fiduciary Trust’s LENZ Therapeutics LENZ Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$849K Sell
149,440
-547
-0.4% -$4.41K ﹤0.01% 3082
2026
Q1 		$1.37M Buy
+149,987
New +$2.11M ﹤0.01% 2764

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Vanguard Fiduciary Trust's LENZ Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its LENZ Therapeutics (LENZ) stake by 0.36% in Q2 2026, selling an estimated $4.41K and leaving 149,440 shares worth $849K. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

Vanguard Fiduciary Trust first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.37M in Q1 2026. 143 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Vanguard Fiduciary Trust held 149,440 shares of LENZ Therapeutics worth $849K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 547 LENZ Therapeutics shares in Q2 2026, an estimated $4.41K.
  • LENZ Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3082 holding.
  • Vanguard Fiduciary Trust first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's LENZ Therapeutics position peaked at $1.37M in Q1 2026.
  • 143 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.